{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T23:12:52Z","timestamp":1783984372468,"version":"3.55.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T00:00:00Z","timestamp":1596758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["COVID-19"],"award-info":[{"award-number":["COVID-19"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["OV3-170627"],"award-info":[{"award-number":["OV3-170627"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.cmi.2020.08.005","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T21:57:00Z","timestamp":1597096620000},"page":"1436-1446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks"],"prefix":"10.1016","volume":"26","author":[{"given":"Denise J.","family":"Wooding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horacio","family":"Bach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2020.08.005_bib1","doi-asserted-by":"crossref","first-page":"m1256","DOI":"10.1136\/bmj.m1256","article-title":"Covid-19: FDA approves use of convalescent plasma to treat critically ill patients","volume":"368","author":"Tanne","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2020.08.005_bib2","author":"World Health Organization"},{"key":"10.1016\/j.cmi.2020.08.005_bib3","doi-asserted-by":"crossref","first-page":"104541","DOI":"10.1016\/j.antiviral.2019.104541","article-title":"Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase","volume":"169","author":"Brown","year":"2019","journal-title":"Antivir Res"},{"key":"10.1016\/j.cmi.2020.08.005_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","volume":"9","author":"Sheahan","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cmi.2020.08.005_bib5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41467-019-13940-6","article-title":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","volume":"11","author":"Sheahan","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.cmi.2020.08.005_bib6","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1073\/pnas.1922083117","article-title":"Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection","volume":"117","author":"de Wit","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cmi.2020.08.005_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","author":"Wang","year":"2020","journal-title":"The Lancet"},{"key":"10.1016\/j.cmi.2020.08.005_bib8","series-title":"Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19. Infectious Diseases (except HIV\/AIDS)","author":"Magagnoli","year":"2020"},{"key":"10.1016\/j.cmi.2020.08.005_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.8857","article-title":"Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial","volume":"3","author":"Borba","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cmi.2020.08.005_bib10","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2020.08.005_bib11","doi-asserted-by":"crossref","DOI":"10.1007\/s12325-020-01351-9","article-title":"Anti COVID-19 drugs: need for more clinical evidence and global action","author":"Khan","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.cmi.2020.08.005_bib12","article-title":"Convalescent plasma: new evidence for an old therapeutic tool?","author":"Marano","year":"2015","journal-title":"Blood Transfus"},{"key":"10.1016\/j.cmi.2020.08.005_bib13","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/14787210.2017.1328278","article-title":"Use of human immunoglobulins as an anti-infective treatment: the experience so far and their possible re-emerging role","volume":"15","author":"Bozzo","year":"2017","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.cmi.2020.08.005_bib14","doi-asserted-by":"crossref","first-page":"599","DOI":"10.7326\/0003-4819-145-8-200610170-00139","article-title":"Meta-Analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?","volume":"145","author":"Luke","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2020.08.005_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4783","article-title":"Treatment of 5 critically ill patients with COVID-19 with convalescent plasma","author":"Shen","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2020.08.005_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1511812","article-title":"Evaluation of convalescent plasma for Ebola virus disease in Guinea","volume":"374","author":"van Griensven","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2020.08.005_bib17","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.cmi.2020.08.005_bib18","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1038\/nm1143","article-title":"Severe acute respiratory syndrome","volume":"10","author":"Peiris","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.cmi.2020.08.005_bib19","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2020.08.005_bib20","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.10044","article-title":"Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial","author":"Li","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2020.08.005_bib21","series-title":"Convalescent Plasma for COVID-19. A randomized clinical trial","author":"Gharbharan","year":"2020"},{"key":"10.1016\/j.cmi.2020.08.005_bib22","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3851\/IMP3243","article-title":"Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience","volume":"23","author":"Ko","year":"2018","journal-title":"Antivir Ther"},{"key":"10.1016\/j.cmi.2020.08.005_bib23","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3947\/ic.2016.48.2.118","article-title":"Clinical presentation and outcomes of Middle East respiratory syndrome in the Republic of Korea","volume":"48","author":"Choi","year":"2016","journal-title":"Infect Chemother"},{"key":"10.1016\/j.cmi.2020.08.005_bib24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s10096-004-1271-9","article-title":"Use of convalescent plasma therapy in SARS patients in Hong Kong","volume":"24","author":"Cheng","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2020.08.005_bib25","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1469-0691.2004.00956.x","article-title":"Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients","volume":"10","author":"Soo","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2020.08.005_bib26","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/jac\/dki346","article-title":"Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital","volume":"56","author":"Yeh","year":"2005","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2020.08.005_bib27","first-page":"119","article-title":"Treatment of severe acute respiratory syndrome with convalescent plasma","volume":"9","author":"Wong","year":"2003","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.cmi.2020.08.005_bib28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1473-0502(03)00109-5","article-title":"Letter to the editor","volume":"29","author":"Kong","year":"2003","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.cmi.2020.08.005_bib29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.amsu.2020.06.018","article-title":"Severe refractory COVID-19 patients responding to convalescent plasma; a case series","volume":"56","author":"Abdullah","year":"2020","journal-title":"Ann Med Surg"},{"key":"10.1016\/j.cmi.2020.08.005_bib30","doi-asserted-by":"crossref","first-page":"102867","DOI":"10.1016\/j.transci.2020.102867","article-title":"Life-saving effect of convalescent plasma treatment in covid-19 disease: clinical trial from eastern Anatolia","author":"Erkurt","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.cmi.2020.08.005_bib31","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140200","article-title":"Early safety indicators of COVID-19 convalescent plasma in 5,000 patients","author":"Joyner","year":"2020","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cmi.2020.08.005_bib32","series-title":"Convalescent plasma treatment of severe COVID-19: a matched control study Infectious Diseases (except HIV\/AIDS)","author":"Liu","year":"2020"},{"key":"10.1016\/j.cmi.2020.08.005_bib33","first-page":"2020006964","article-title":"Use of convalescent plasma in hospitalized patients with Covid-19\u2014case series","author":"Hegerova","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2020.08.005_bib34","doi-asserted-by":"crossref","first-page":"102866","DOI":"10.1016\/j.transci.2020.102866","article-title":"First case of convalescent plasma transfusion in a child with COVID-19-associated severe aplastic anemia","author":"Figlerowicz","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.cmi.2020.08.005_bib35","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.3346\/jkms.2020.35.e239","article-title":"Convalescent plasma therapy in coronavirus disease 2019: a case report and suggestions to overcome obstacles","volume":"35","author":"Im","year":"2020","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.cmi.2020.08.005_bib36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/infdis\/jiaa228","article-title":"Effect of convalescent plasma therapy on viral shedding and survival in COVID-19 patients","volume":"222","author":"Zeng","year":"2020","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2020.08.005_bib37","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1073\/pnas.2004168117","article-title":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients","volume":"117","author":"Duan","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cmi.2020.08.005_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25882","article-title":"Treatment with convalescent plasma for COVID-19 patients in Wuhan, China","author":"Ye","year":"2020","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.cmi.2020.08.005_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2020.03.039","article-title":"Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection","author":"Zhang","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.cmi.2020.08.005_bib40","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.3346\/jkms.2020.35.e149","article-title":"Use of convalescent plasma therapy in two COVID-19 patients with acute respiratory distress syndrome in Korea","volume":"35","author":"Ahn","year":"2020","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.cmi.2020.08.005_bib41","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/thoraxjnl-2016-209313","article-title":"Predictors of mortality in Middle East respiratory syndrome (MERS)","volume":"73","author":"Hong","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.cmi.2020.08.005_bib42","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3343\/alm.2016.36.4.393","article-title":"Possible transfusion-related acute lung injury following convalescent plasma transfusion in a patient with Middle East respiratory syndrome","volume":"36","author":"Chun","year":"2016","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.cmi.2020.08.005_bib43","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jiu396","article-title":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis","volume":"211","author":"Mair-Jenkins","year":"2015","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2020.08.005_bib44","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1017\/S0950268820001351","article-title":"Treatment and preliminary outcomes of 150 acute care patients with COVID-19 in a rural health system in the Dakotas","volume":"148","author":"Enzmann","year":"2020","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.cmi.2020.08.005_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25961","article-title":"Convalescent plasma transfusion for the treatment of COVID-19: systematic review","author":"Rajendran","year":"2020","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.cmi.2020.08.005_bib46","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.10218","article-title":"A\u00a0randomized trial of convalescent plasma for COVID-19\u2014potentially hopeful signals","author":"Casadevall","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2020.08.005_bib47","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/clinids\/21.1.150","article-title":"Return to the past: the case for antibody-based therapies in infectious diseases","volume":"21","author":"Casadevall","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2020.08.005_bib48","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1172\/JCI138003","article-title":"The convalescent sera option for containing COVID-19","volume":"130","author":"Casadevall","year":"2020","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cmi.2020.08.005_bib49","doi-asserted-by":"crossref","DOI":"10.1172\/JCI138745","article-title":"Deployment of convalescent plasma for the prevention and treatment of COVID-19","author":"Bloch","year":"2020","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cmi.2020.08.005_bib50","first-page":"12926","article-title":"Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how?","author":"Tiberghien","year":"2020","journal-title":"Vox Sang"},{"key":"10.1016\/j.cmi.2020.08.005_bib51","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1365-2141.2009.07840.x","article-title":"Transfusion-related acute lung injury (TRALI): a clinical review with emphasis on the critically ill","volume":"147","author":"Benson","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cmi.2020.08.005_bib52","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.micinf.2020.02.006","article-title":"Is COVID-19 receiving ADE from other coronaviruses?","volume":"22","author":"Tetro","year":"2020","journal-title":"Microbe. Infect"},{"key":"10.1016\/j.cmi.2020.08.005_bib53","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1473-3099(20)30141-9","article-title":"Convalescent plasma as a potential therapy for COVID-19","volume":"20","author":"Chen","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2020.08.005_bib54","series-title":"Viral kinetics and antibody responses in patients with COVID-19. Infectious Diseases (except HIV\/AIDS)","author":"Tan","year":"2020"},{"key":"10.1016\/j.cmi.2020.08.005_bib55","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3201\/eid2209.151164","article-title":"Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia","volume":"22","author":"Arabi","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2020.08.005_bib56","first-page":"1","article-title":"Use of Convalescent whole blood or plasma collected from patients recovered from Ebola virus disease for transfusion, as an empirical treatment during outbreaks","volume":"1","author":"World Health Organization","year":"2014","journal-title":"Interim Guidance Natl Health Authorities Blood Transfus Serv"},{"key":"10.1016\/j.cmi.2020.08.005_bib57","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.3201\/eid2112.151421","article-title":"Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea","volume":"21","author":"Park","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2020.08.005_bib58","series-title":"Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)","year":"2020"},{"key":"10.1016\/j.cmi.2020.08.005_bib59","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3201\/eid2307.170310","article-title":"MERS-CoV antibody responses 1 year after symptom onset, South Korea, 2015","volume":"23","author":"Choe","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2020.08.005_bib60","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1465-9921-6-5","article-title":"Dynamic changes of serum SARS-Coronavirus IgG, pulmonary function and radiography in patients recovering from SARS after hospital discharge","volume":"6","author":"Xie","year":"2005","journal-title":"Respir Res"},{"key":"10.1016\/j.cmi.2020.08.005_bib61","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1056\/NEJMc070348","article-title":"Disappearance of antibodies to SARS-associated coronavirus after recovery","volume":"357","author":"Cao","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2020.08.005_bib62","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa310","article-title":"Profiling early humoral response to diagnose novel coronavirus disease (COVID-19)","author":"Guo","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2020.08.005_bib63","series-title":"COVID-19 convalescent plasma\u2014emergency INDs","author":"Research C for","year":"2020"},{"key":"10.1016\/j.cmi.2020.08.005_bib65","doi-asserted-by":"crossref","first-page":"P19","DOI":"10.1164\/rccm.2020C1","article-title":"Diagnosis and management of COVID-19 disease","volume":"201","author":"Jamil","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2020.08.005_bib66","article-title":"Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic","author":"Prompetchara","year":"2020","journal-title":"Asian Pac J Allergy Immunol"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X20304821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X20304821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:23:50Z","timestamp":1778592230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X20304821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":65,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1198743X20304821"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2020.08.005","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2020.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2020.07.023","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2018.07.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}